Inventor · disambiguated record
Michael Brian Welch
Also filed as: WELCH MICHAEL BRIAN · Welch michael b
5 granted patents·5 pending applications·4 citations·filing 2021–2024
66Inventor score
Top patents by PatentIndex Score
10 records- 0190US11873295B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Granted Jan 16, 2024·3 cites·125 claims
- 0281US11649227B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2021·Granted May 16, 2023·1 cites·20 claims
- 0373US11964968B2Compounds useful for inhibiting RET kinaseLILLY CO ELI·Filed 2023·Granted Apr 23, 2024·0 cites·23 claims
- 0469US2024051948A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 0568US2024383878A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2024·Application pending·0 cites
- 0666US2023286960A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 0765US11613533B2Compounds useful for inhibiting RET kinaseLILLY CO ELI·Filed 2021·Granted Mar 28, 2023·0 cites·25 claims
- 0863US2023014445A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Application pending·0 cites
- 0958US2024018115A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 1056US11878970B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Granted Jan 23, 2024·0 cites·65 claims
Join the waitlist — get patent alerts
Get an alert when Michael Brian Welch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →